CHICAGO, June 4 (Reuters) - A new wave of experimental
cancer drugs that directly recruit the immune system's powerful
T cells could begin reaching patients next year, according to
companies presenting new data at the annual meeting of the
American Society of Clinical Oncology.
Read more
No comments:
Post a Comment